Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FINISHER: Dexamethasone in Aneurysmal Subarachnoid Hemorrhage
NCT05132920Phase 3Completed
- Sponsor
- University Hospital Bonn
- Start
- Dec 2021
- Primary completion
- Sep 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in aneurysmal subarachnoid hemorrhage (SAH) (2 arms), sponsored by University Hospital Bonn. Primary endpoint: modified Rankin Scale at 6 months. Started Dec 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT05132920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05132920.